Adhera Therapeutics, Inc.
ATRX0.00010.00% ( 0.0000 )
Q3 FY2023 Earnings
Financial report interval: 2023.06.30 - 2023.09.30
Overview: Adhera Therapeutics, Inc.(ATRX) the EBIT is -269.5 K (+50.78%);the EPS is -0.83 (-44.78%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B50.78%
----
----
EPS
-0.8344.78%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf